Sort
21,453 grants matching “tuberculosis”
Improving identification of HIV-associated neurocognitive disorder (HAND) in Latin America: A multimodal approach to HAND in Peru
$197,480Monica Maria Diaz · Univ Of North Carolina Chapel Hill · K23 · FY2024 · MH
Improving identification of HIV-associated neurocognitive disorder (HAND) in Latin America: A multimodal approach to HAND in Peru
$197,480Monica Maria Diaz · Univ Of North Carolina Chapel Hill · K23 · FY2025 · MH
Unleashing CD8+ T Cells for TB Defense
$197,475Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · AI
Identification of new compounds against fungal microbes
$197,448Maurizio Del Poeta · State University New York Stony Brook · R21 · FY2014 · AI
Comparative Effectiveness of Rapid TB Diagnostics in Uganda
$197,402David Wesley Dowdy · Johns Hopkins University · R21 · FY2014 · AI
Synthesizability-constrained expansion and multi-objective evolution of antitubercular compounds
$197,349Joel Stephen Freundlich · Rbhs-New Jersey Medical School · R21 · FY2022 · AI
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
$197,338Judith Alissa Hahn · University Of California, San Francisco · K24 · FY2022 · AA
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
$197,338Judith Alissa Hahn · University Of California, San Francisco · K24 · FY2021 · AA
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
$197,338Judith Alissa Hahn · University Of California, San Francisco · K24 · FY2023 · AA
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
$197,338Judith Alissa Hahn · University Of California, San Francisco · K24 · FY2020 · AA
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
$197,338Judith Alissa Hahn · University Of California, San Francisco · K24 · FY2019 · AA
Interrupting HIV and TB stigma in the household during TB contact investigation in Uganda
$197,308John Lucian Davis · Yale University · R21 · FY2019 · TW
Emory/Georgia TB Research Advancement Center (TRAC)
$197,283Neel Rajnikant Gandhi · Emory University · P30 · FY2022 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$197,283Henry M Blumberg · Emory University · P30 · FY2022 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$197,282Nippie Sarita Shah · Emory University · P30 · FY2022 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$197,281Rafick-Pierre Sekaly · Emory University · P30 · FY2022 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$197,281Cheryl Liane Day · Emory University · P30 · FY2022 · AI
Large-scale Gene Deletion in Infectious M. tuberculosis
$197,217Weill Medical College Of Cornell Univ · R21 · FY2005 · AI
COMPLICATIONS OF HIV DISEASE AGENDA
$197,196Mount Sinai School Of Medicine Of Cuny · U01 · FY2001 · AI
COMPLICATIONS OF HIV DISEASE AGENDA
$197,196Mount Sinai School Of Medicine Of Cuny · U01 · FY2000 · AI
Using genetics and multi-scale imaging to understand the mechanisms underlying mycobacteriophage host choice
$197,175Eric Joseph Rubin · Harvard School Of Public Health · R21 · FY2022 · AI
The Role of Cell Wall Lipids in Pathogenesis of Rifampin-Resistant TB
$197,159Petros C Karakousis · Johns Hopkins University · R01 · FY2014 · AI
Safety and tolerability of new and repurposed drugs for MDR-TB treatment
$196,981Gustavo Eduardo Velasquez · University Of California, San Francisco · K08 · FY2022 · AI
FEND-TB
$196,955Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
CD1 IMMUNE RESPONSES AND VACCINES IN ANIMAL MODELS OF TB
$196,905Brigham And Women'S Hospital · R01 · FY2003 · AI